Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
Available in National Diet Library
Find on the publisher's website
NDL Digital Collections
Digital data available
Check on the publisher's website
DOI[10.1111/cas.15074]to the data of the same series
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 富田, 晃正
- Publication, Distribution, etc.
- Publication Date
- 2022
- Publication Date (W3CDTF)
- 2022
- Alternative Title
- MEK阻害剤は神経芽腫細胞に対するGD2特異的CRT-T細胞療法の抗腫瘍効果を高める
- Degree grantor/type
- 京都府立医科大学
- Date Granted
- 2022-01-14
- Date Granted (W3CDTF)
- 2022-01-14